Bogdanov, P.; Ramos, H.; Valeri, M.; Deà s-Just, A.; Huerta, J.; Simó, R.; Hernández, C.
Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model. Biomedicines 2022, 10, 465.
https://doi.org/10.3390/biomedicines10020465
AMA Style
Bogdanov P, Ramos H, Valeri M, Deà s-Just A, Huerta J, Simó R, Hernández C.
Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model. Biomedicines. 2022; 10(2):465.
https://doi.org/10.3390/biomedicines10020465
Chicago/Turabian Style
Bogdanov, Patricia, Hugo Ramos, Marta Valeri, Anna Deà s-Just, Jordi Huerta, Rafael Simó, and Cristina Hernández.
2022. "Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model" Biomedicines 10, no. 2: 465.
https://doi.org/10.3390/biomedicines10020465
APA Style
Bogdanov, P., Ramos, H., Valeri, M., Deà s-Just, A., Huerta, J., Simó, R., & Hernández, C.
(2022). Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model. Biomedicines, 10(2), 465.
https://doi.org/10.3390/biomedicines10020465
